What is Rise Science?
Rise Science operates at the intersection of behavioral science and mobile technology. The company provides a specialized application that synthesizes individual sleep data to deliver personalized, daily, and weekly insights. By focusing on sleep debt and circadian rhythm optimization, the platform helps users improve their cognitive performance and overall well-being. Its market position is defined by a dual-focus approach: serving individual consumers while simultaneously offering enterprise-grade solutions for teams that require peak mental acuity. This versatility has allowed Rise Science to carve out a unique niche in the digital health market, moving beyond simple tracking to provide meaningful, science-backed behavioral interventions.
How much funding has Rise Science raised?
Rise Science has raised a total of $15.5M across 2 funding rounds:
Angel/Seed
$5.5M
Series A
$10M
Angel/Seed (2018): $5.5M with participation from High Alpha, True Ventures, and Freestyle
Series A (2021): $10M led by Goodwater Capital
Key Investors in Rise Science
Goodwater Capital
Goodwater Capital is a consumer tech investment firm that empowers exceptional entrepreneurs to create positive change in the world, focusing on innovative companies across financial services, retail, and healthcare.
High Alpha
High Alpha is a venture firm that creates and funds B2B SaaS companies, partnering with founders to build businesses that reach their full potential in sectors such as healthcare and sales enablement.
True Ventures
True Ventures is a founder-first venture capital firm that partners with creative teams at the earliest stages, providing capital and guidance to help build enduring technology and artificial intelligence-driven companies.
What's next for Rise Science?
With the recent capital injection, Rise Science is well-positioned to deepen its integration within the enterprise software ecosystem. The company is expected to prioritize the enhancement of its predictive analytics engine, ensuring that its sleep-optimization tools remain at the forefront of the wellness industry. Strategic growth will likely involve expanding its B2B offerings, targeting organizations that prioritize employee health as a driver of productivity and retention. As the firm continues to scale, the focus will remain on maintaining the scientific rigor of its insights while broadening its reach to meet the demands of a global, performance-oriented workforce. The backing from prominent venture firms provides not only the necessary liquidity but also the strategic guidance required to navigate the complexities of the rapidly evolving health-tech sector.
See full Rise Science company page
